QNCXQuince Therapeutics Inc. Common Stock
33.93USD-1.85%Mkt Cap: 34.51M $P/E: —3d ago
Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP…